We regularly work with HCPs and HCOs, for example inviting them to speak at medical educational meetings or seeking their advice and expertise on our medications and services to patients and the healthcare community. Individuals are compensated for providing these services to the industry at a fair market value and these payments are referred to as Transfers of Value (ToV). It can also include, for example, sponsoring an individual to attend an important medical congress by meeting their registration, reasonable travel and accommodation costs (also known as a benefit in kind). Organisations may be provided with funding to help with education for HCPs.

Detailed information on individual transfers of value can be accessed through www.janssentransferofvalue.com, a secure online portal, provided by Johnson & Johnson.

To enable Johnson & Johnson to comply with its regulatory requirements, payments or other transfers of value (“ToV”) including benefits in kind and/or travel, made by Johnson & Johnson to Recipient for the current reporting year will be stored on Johnson & Johnson’s database and disclosed annually as required by Johnson & Johnson’s industry Code of Practice, the Association of British Pharmaceutical Industry (ABPI) Code in the UK and the Irish Pharmaceutical Healthcare Association (IPHA) Code in Ireland.

Johnson & Johnson believes transparency is critical to confidence in the industry by consumers and will disclose annually any payments made by Johnson & Johnson to Recipient on an individual basis. Recipient has the opportunity to object to Janssen making the disclosure on an individual basis by emailing our disclosure inbox: disclosure@janssen.co.uk

For further information please email disclosure@janssen.co.uk.